Home>Topics>Companies>Express Scripts

Express Scripts ESRX

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
    1. Biosimilars on the horizon in the U.S.

      Headlines

      Fri, 12 Sep 2014

      the FDA finally opens the door for biosimiars in the U.S. it could save as much as $250B per year by 2024 according to Express Scripts ( ESRX -1.3% ). There are 14 biotech meds being targeted by pharmaceutical firms who want to sell cheaper versions

    2. New Morningstar Analyst Report for Gilead Sciences Inc

      Stock Reports

      Thu, 11 Sep 2014

      hepatitis C drug Sovaldi sees strong competition from firms like Bristol and AbbVie, or if pharmacy benefit managers like Express Scripts are able to aggressively negotiate pricing once more all-oral treatment options reach the market. We're raising our

    3. How To Evaluate Express Scripts' Timeliness

      Headlines

      Tue, 9 Sep 2014

      By Valuentum : Express Scripts (NASDAQ: ESRX ) is the largest pharmacy benefit management company in the US, and ranks among the best with respect to its return

    4. New Morningstar Analyst Report for Express Scripts

      Stock Reports

      Mon, 8 Sep 2014

      will create a moderate headwind for Express Scripts . If suppliers are successful with ..... product through consolidation, then Express Scripts could lose some of its negotiating ..... more choice among retail pharmacies. Express Scripts is the largest PBM with over 1.3

    5. Company 401k via NYLife has not ticker

      Commentary

      Sun, 7 Sep 2014

      ticker to follow via my MS portfolio. How is this best handled to track within the portfolio? I entered the fund name ( Express Scripts Bond Index Fund) but it does not show as an offering. I was told it was because it was a hybrid fund - not a pure mutal

    6. Express Scripts Delivers Significant Growth Potential At A Reasonable Valuation

      Headlines

      Sun, 7 Sep 2014

      By Stock Market Sherpa : Express Scripts Holdings (NASDAQ: ESRX ..... mergers and acquisitions, Express Scripts is well-positioned as a leader ..... recent investor presentation, Express Scripts highlighted two important facts

    7. New Morningstar Analyst Report for AmerisourceBergen Corp

      Stock Reports

      Mon, 25 Aug 2014

      advantageous generic drug pricing. The firm also recently won the Express Scripts mail order contract and, while this contract yields a lower ..... macro trends. We have accounted for the firm’s recent Express Scripts and Walgreen contract wins, which will add significantly

    8. A Few Picks to Tide Over the Bargain-Hunters

      Headlines

      Sun, 17 Aug 2014

      action like it did in 2008-2009. Express Scripts ESRX | 4 Stars | Wide Moat This pharmacy ..... the industry's dominant players, Express Scripts should pick up a nice tailwind as ..... cutting remains in focus. (For more on Express Scripts , see markets editor Jeremy Glaser

    9. Horizon Pharma: Upbeat 2015 Guidance Increases Confidence

      Headlines

      Mon, 11 Aug 2014

      management thinks that it can mitigate the downside risks of Duexis and Vimovo being taken off formularies by Caremark and Express Scripts in 2015. However, there are risks to these growth estimates, and they should not be taken lightly. I am lowering my

    10. Update: Theravance Reports Increased Patient Access And High Confidence In Dividend

      Headlines

      Thu, 7 Aug 2014

      the CVS Caremark formulary exclusion list and will be available at Tier 3 without restriction effective January 1, 2015. Express Scripts , BREO will move from Tier 3 to preferred Tier 2 unrestricted position in the Basic Formulary starting in 2015, but unfortunately

    « Prev12345Next »
    Content Partners